◼ Archived
Health
🔮 fades ✗
What to know about the new mRNA flu vaccine
Health coverage highlights FDA approval of Moderna's new mRNA flu vaccine and emerging studies on broader antibody responses.
Gsk
6 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
🔮 fades ✓
Moderna Rises 6% Despite GSK Moving Rival mRNA Flu Vaccine to Phase III
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✗
GSK catches phase 3 fever after mRNA flu vaccine beats standard shots
GSK advances its mRNA flu vaccine candidate to phase 3 trials following successful mid-stage performance data.
◼ Archived
Business
🔮 fades ✓
There’s a big change for this year’s flu shot: When should you be vaccinated?
GSK is advancing a new mRNA flu vaccine to Phase III trials after the candidate outperformed standard vaccinations in earlier testing.
◼ Archived
Health
🔮 fades ✗
Shingles vaccine linked to 24% lower dementia risk
Recent studies link the shingles vaccine to significant reductions in dementia and cardiovascular disease risks.
◼ Archived
Business
🔮 fades ✗
GSK unveils 3-year cost-saving plan to fund late-stage R&D, move research HQ to AZ's backyard
GSK is launching a $2.5 billion cost-saving initiative to accelerate its late-stage drug pipeline and relocate its research headquarters.